Value of three-dimensional hysterosalpingo-contrast sonography with SonoVue in the assessment of tubal patency
Article first published online: 29 JUN 2012
Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.
Ultrasound in Obstetrics & Gynecology
Volume 40, Issue 1, pages 93–98, July 2012
How to Cite
Zhou, L., Zhang, X., Chen, X., Liao, L., Pan, R., Zhou, N. and Di, N. (2012), Value of three-dimensional hysterosalpingo-contrast sonography with SonoVue in the assessment of tubal patency. Ultrasound Obstet Gynecol, 40: 93–98. doi: 10.1002/uog.11085
- Issue published online: 29 JUN 2012
- Article first published online: 29 JUN 2012
- Accepted manuscript online: 5 JAN 2012 11:19AM EST
- Manuscript Accepted: 22 NOV 2011
- contrast agent BR1;
- Fallopian tube;
- hysterosalpingo-contrast sonography;
To investigate the accuracy of transvaginal three-dimensional hysterosalpingo-contrast sonography using SonoVue (3D SonoVue-HyCoSy) in the assessment of Fallopian tubal patency.
We recruited 75 infertile patients undergoing 3D SonoVue-HyCoSy before standard diagnostic laparoscopy with chromotubation (lap and dye). Tubal patency was assessed by automated 3D coded contrast imaging (3D SonoVue-HyCoSy), and the findings were compared with the results of lap and dye.
For detecting tubal patency among the 150 Fallopian tubes assessed, 3D SonoVue-HyCoSy had a sensitivity of 93.5%, specificity of 86.3%, positive and negative predictive values of 87.8% and 92.6%, respectively, and diagnostic accuracy of 90.0%. The test-positive rates of 3D SonoVue-HyCoSy vs lap and dye were not significantly different (82/150 vs 77/150, P > 0.05).
3D SonoVue-HyCoSy should be considered clinically valuable as a practical, non-invasive, primary investigatory tool for evaluating tubal patency. Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.